IMPACT Therapeutics Market Cap

IMPACT Therapeutics has a market cap or net worth of 10.29 billion as of June 22, 2026.

Market Cap

10.29B

Enterprise Value

10.01B

Revenue

42.57M

Ranking

n/a

PE Ratio

n/a

Stock Price

36.46

Market Cap Chart

Since May 13, 2026, IMPACT Therapeutics's market cap has decreased from 11.56B to 10.29B, a decrease of -10.99%. That is a compound annual growth rate of -65.43%.

Market Cap History

Date	Market Cap	% Change
Jun 22, 2026	10.29B	0.70%
Jun 18, 2026	10.22B	-1.80%
Jun 17, 2026	10.41B	0.48%
Jun 16, 2026	10.36B	1.68%
Jun 15, 2026	10.18B	1.32%
Jun 12, 2026	10.05B	-1.62%
Jun 11, 2026	10.22B	0.82%
Jun 10, 2026	10.14B	-
Jun 9, 2026	10.14B	-1.18%
Jun 8, 2026	10.26B	0.32%
Jun 5, 2026	10.22B	-7.63%
Jun 4, 2026	11.07B	0.10%
Jun 3, 2026	11.06B	-1.33%
Jun 2, 2026	11.21B	-4.74%
Jun 1, 2026	11.76B	6.77%
May 29, 2026	11.02B	7.32%
May 28, 2026	10.27B	-1.48%
May 27, 2026	10.42B	-1.67%
May 26, 2026	10.60B	1.80%
May 22, 2026	10.41B	19.91%
May 21, 2026	8.68B	-16.03%
May 20, 2026	10.34B	-3.51%
May 19, 2026	10.72B	1.68%
May 18, 2026	10.54B	-4.70%
May 15, 2026	11.06B	0.10%
May 14, 2026	11.05B	-4.44%
May 13, 2026	11.56B	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	235.39B
Hansoh Pharmaceutical Group Company	181.65B
Innovent Biologics	132.37B
WuXi Biologics	127.40B
Nanjing Leads Biolabs	10.74B
GenFleet Therapeutics (Shanghai)	10.60B
LongBio Pharma (Suzhou)	10.59B
Ascletis Pharma	10.38B

Market Cap Rankings